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AbstrAct
There is no consensus as to the duration and nature of 
follow-up following surgical resection with curative intent 
of lung cancer. The integration of cancer follow-up into 
primary care is likely to be a key future area for quality 
and cost-effective cancer care. Evidence from other 
solid cancer types demonstrates that such follow-up 
has no adverse outcomes, similar health-related quality 
of life, high patient satisfaction rates at a lower cost to 
the healthcare system. Core elements for successful 
models of shared cancer care are required: clear roles 
and responsibilities, timely effective communication, 
guidance on follow-up protocols and common treatments 
and rapid routes to (re)access specialist care. There 
is thus a need for improved communication between 
hospital specialists and primary care. Unmet needs for 
patients with early stage lung cancer are likely to include 
psychological symptoms and carer stress; the importance 
of smoking cessation may frequently be overlooked or 
underappreciated in the current hospital-based follow-up 
system. There is therefore a need for quality randomised 
controlled trials of patients with resected early stage lung 
cancer to establish optimal protocols for primary care-
based follow-up and to more adequately address patients' 
and carers' unmet psychosocial needs, including the 
crucial role of smoking cessation.
IntroductIon
Lung cancer is the most commonly diagnosed 
cancer worldwide,1 and surgery offers the best 
chance of cure or long-term survival. There 
are variable early stage lung cancer surgical 
rates across developed countries of between 
5% and 21%.2 Patients with resected early 
stage lung cancer have recurrence rates of 
between 30% and 75%,3 and it is likely that 
with increasing interest in and adoption of 
screening for lung cancer,4 rates of those 
having surgery for early stage disease may 
increase. In addition, patients with a previous 
lung cancer are at high risk of developing 
metachronous lung cancers at a rate of 
1%–5% per annum.5
There is no consensus as to the duration 
and nature of follow-up following curative 
surgical resection of lung cancer with the 
most recent American guidelines citing the 
evidence base as ‘weak, low quality’.6 Typi-
cally, after postoperative follow-up, current 
practice involves CT of the chest at 6 months 
and then annually up to 5 years after resec-
tion. The American guidelines recommend 
every 6 months for 2 years,6 although there 
is a wide variation in practice in across coun-
tries with similar healthcare systems. This 
follow-up is normally hospital based, with 
respiratory specialists or thoracic surgeons. 
After lobectomy, local recurrence is most 
common in the first 2 years with the risk of 
recurrence nearly twofold higher (HR 1.86; 
95% CI 1.01 to 3.41) in persistent smokers.7
Cost-effective healthcare relies on the 
provision of appropriate care in the right 
time at the right place; countries with a strong 
primary care component have been demon-
strated to be more cost-effective than those 
that are over-reliant on hospital-led services.8 
As cancer survival rates increase, the focus on 
managing patient flow back into primary care 
is a key area for future-effective and cost-ef-
fective cancer care.9 It is recognised that 
follow-up of patients undergoing palliative 
surgical interventions is very different; these 
patients are likely to benefit from regular 
secondary care contact.10 This article will 
concentrate on follow-up after surgery with 
curative intent for non-small cell lung cancer 
(NSCLC).
the role of primary care in follow-up of patients 
with cancer
There is increasing acceptance of the role of 
primary care in the follow-up of cancer survi-
vors,11–14 and in turn this is seen as increasingly 
critical for the long-term sustainability for 
healthcare systems in many developed coun-
tries.15 In many developed countries, there is 
an increasing financial demand on secondary 
and tertiary care services. There is thus a 
need to better define which clinical services 
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require specialist oversight and which conditions could, 
perhaps with appropriate guidance and oversight,16 17 be 
acceptably managed within primary care.
Evidence from randomised clinical studies in bowel 
and breast cancer follow-up suggests that integrated 
follow-up in primary care has no adverse outcomes, 
similar health-related quality of life and high patient satis-
faction rates.18 19 The results of an Australian randomised 
control trial examining integrated care with hospitals 
and general practitioners (GPs) for patients with pros-
tate cancer also demonstrated that this was a safe and 
acceptable model of care at lower cost to the healthcare 
system.20 GPs feel confident and enabled to contribute to 
long-term cancer care21 and cancer survivors are satisfied 
with care delivery in primary care.22
There have been a number of studies examining 
follow-up of lung cancer in different settings. A retro-
spective cohort study in Japan reported the outcomes 
of postoperative patients with NSCLC dependent on 
follow-up with either thoracic surgeons or chest physi-
cians.23 Survival in more advanced stage disease was better 
with the chest physician group; there was data to suggest 
that the use of regular CT chest scans may improve detec-
tion of recurrence (or new primary) to enable therapy 
with curative intent (regardless of doctor in charge of 
follow-up).
Another retrospective cohort study from Canada 
describes outcomes of postsurgical patients with 
NSCLC, comparing thoracic surgeon followed by other 
health professionals.24 Despite hospital clinic follow-up, 
two-thirds of recurrences were detected by the patient’s 
GP, with no overall survival differences. It was postulated 
that GP-based care might be associated with 75% cost 
savings from follow-up. A randomised controlled trial 
from the UK comparing nurse-led care with conventional 
approaches for advanced NSCLC reported improved 
satisfaction, earlier recognition of deterioration, better 
emotional functioning, fewer consultations and no differ-
ence in survival with nurse-led care.25 Nurse-led care is 
reported to be acceptable to patients, carers, GPs and 
treating physicians.26 Such non-specialist follow-up may 
therefore be acceptable as long as there are clear proto-
cols including the ability to refer to specialists easily and 
access to appropriate radiology.26
The potential shift in the care for patient with cancer 
with greater GP involvement also raises concerns that 
GP workloads may be increased.21 There is additional 
concern that perhaps GPs will see very few of these cases 
in their practice and thus may not be adequately confi-
dent or have sufficient experience to safely follow-up 
these patients.15 27 The proposed solution in this situa-
tion would be the use of a protocol in conjunction with 
clinical acumen to guide follow-up.28 Evidence suggests 
that certain core elements for successful models of shared 
cancer care are required: clear roles and responsibilities 
for GPs, timely effective communication about care, 
guidance on follow-up protocols and management of 
common treatment side effects and rapid routes to access 
specialist care.16 17 20 Therefore, a more collaborative and 
integrated approach would allow GPs to participate more 
with the follow-up care of patients with cancer, perhaps 
with integration with virtual or remote monitoring clinics 
from secondary care.
In some countries, access to specialist care varies, 
notably, specialist visits in populations that have a lower 
income or education levels are lower. The inequity in 
specialist access favours the populations with higher 
income and education in Organisation for Economic 
Co-operation and Development countries.22 23 29 30 Access 
to GPs, which is comparably better than access to special-
ists, would potentially improve this inequity and allow the 
same (or improved) standards of care.
unmet needs for patients with lung cancer
As acknowledged in the National Institute for Health and 
Care Excellence lung cancer clinical guidelines, there 
are sparse data examining unmet needs for patients with 
early stage lung cancer.10 Interviews with patients with 
lung cancer (with more advanced stage) have identi-
fied at least moderate levels of anxiety and depression.31 
A further study reported that hospital consultants were 
failing to recognise anxiety in many patients and largely 
overlooked the needs of informal carers (in whom it 
was reported had the greatest onus of care).32 Key areas 
of unmet need may be most apparent during periods 
away from acute care.32 Other in depth interviews with 
patients with lung cancer and carers identified feelings 
of isolation and identified a need for coordinated fami-
ly-oriented care.33 Patients identified a reliance on their 
hospital-based consultant and found it difficult to tran-
sition back to primary (or palliative) care. Variations in 
perceptions of care may be associated with a patients’ 
educational level, with a higher level of education associ-
ated with more focus on the logistics of care, rather than 
the psychosocial aspects.34
There is a further unmet need to support smoking 
cessation in lung cancer survivors with a 5-year survival 
rate following resection for lung cancer of 77% in those 
able to quit and 33% in those unable to quit smoking.7 
Between our two institutions, 33%–62% of newly diag-
nosed lung cancer cases between 2015 and 2016 were 
current smokers at the time of their diagnosis (unpub-
lished data). Physicians and surgeons who treat lung 
cancer give limited smoking cessation advice and imple-
mentation of plans due to limited resources.35 Smoking 
cessation and support for other behaviour change are 
key roles of primary care with links to community-based 
resources to support patients to stop smoking and adopt 
a healthier lifestyle.
Therefore, the present system of hospital-based care 
may not be adequately identifying all the needs of a 
patient with lung cancer, in particular, psychosocial 
aspects. There is further need for improved communi-
cation between hospital specialists and GPs33 36 37 and 
a more personalised explanation of treatment plan for 
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patients.38 It is already accepted that primary care physi-
cians are motivated and capable of providing follow-up 
to patients with cancer after their initial treatment, with 
good satisfaction among patients. Additionally, there is 
an identified economic need to decentralise care away 
from secondary and tertiary centres where possible.15
We contend that there is a need for quality randomised 
controlled trials of patients with resected early stage lung 
cancer to elucidate suitable patient populations for GP-led 
follow-up, development of protocols for optimal follow-up, 
more adequately address patients’ and carers’ unmet 
psychosocial needs and perform an economic evaluation of 
such an approach to guide future follow-up of these high-
risk patients. There is further need for the development 
of a quality lung cancer registries (similar to the highly 
successful UK-based National Lung Cancer Audit data-
base)39 that will not only lead to improved patient care but 
also may facilitate registry-based trials in the future.40 41
conclusIon
Currently, there is inadequate data to inform the optimal 
care of patients who have had surgery for early stage lung 
cancer with curative intent. The current hospital-based 
system may not be addressing holistic patient-oriented 
care (including smoking cessation) adequately, together 
with the suboptimal use of secondary and tertiary hospital 
resources. High quality data and randomised studies are 
required to evaluate these key issues and improve care 
for these patients.
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